BioPlus Acquisition Corp Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioPlus Acquisition are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days BioPlus Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, BioPlus Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 635.5 K |
BioPlus |
BioPlus Acquisition Relative Risk vs. Return Landscape
If you would invest (100.00) in BioPlus Acquisition Corp on December 25, 2024 and sell it today you would earn a total of 100.00 from holding BioPlus Acquisition Corp or generate -100.0% return on investment over 90 days. BioPlus Acquisition Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than BioPlus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioPlus Acquisition Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioPlus Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioPlus Acquisition Corp, and traders can use it to determine the average amount a BioPlus Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BIOS |
Based on monthly moving average BioPlus Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioPlus Acquisition by adding BioPlus Acquisition to a well-diversified portfolio.
BioPlus Acquisition Fundamentals Growth
BioPlus Stock prices reflect investors' perceptions of the future prospects and financial health of BioPlus Acquisition, and BioPlus Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioPlus Stock performance.
| Return On Asset | -0.0072 | |||
| Current Valuation | 215.16 M | |||
| Shares Outstanding | 19.37 M | |||
| Price To Earning | (3.62) X | |||
| EBITDA | (1.17 M) | |||
| Cash And Equivalents | 294.69 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5 M | |||
| Debt To Equity | 7.23 % | |||
| Book Value Per Share | (0.86) X | |||
| Cash Flow From Operations | (691.47 K) | |||
| Earnings Per Share | 0.21 X | |||
| Total Asset | 238.32 M | |||
| Retained Earnings | (14.78 M) | |||
| Current Asset | 183.69 M | |||
| Current Liabilities | 152.76 M | |||
Things to note about BioPlus Acquisition Corp performance evaluation
Checking the ongoing alerts about BioPlus Acquisition for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioPlus Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioPlus Acquisition is not yet fully synchronised with the market data | |
| BioPlus Acquisition has some characteristics of a very speculative penny stock | |
| BioPlus Acquisition has a very high chance of going through financial distress in the upcoming years | |
| BioPlus Acquisition Corp currently holds about 294.69 K in cash with (691.47 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 49.0% of the company shares are held by company insiders |
- Analyzing BioPlus Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioPlus Acquisition's stock is overvalued or undervalued compared to its peers.
- Examining BioPlus Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioPlus Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioPlus Acquisition's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioPlus Acquisition's stock. These opinions can provide insight into BioPlus Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |